Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Proteasome Inhibitors
67 Products
67 Products
619 Diseases
42140 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
124
248
372
496
620
744
868
992
1116
1240
bortezomib
/ Generic mfg.
carfilzomib
/ Generic mfg.
Ninlaro
(ixazomib) / Takeda
Repatha
(evolocumab) / Amgen, Astellas
Praluent
(alirocumab) / Sanofi, Regeneron
Leqvio
(inclisiran) / Novartis
aclarubicin
/ Generic mfg.
enlicitide decanoate
(MK-0616) / Merck (MSD), UCB
bococizumab
(RN316) / Pfizer
Sintbilo
(tafolecimab) / Innovent Biologics
lerodalcibep
(LIB003) / LIB Therap
marizomib
(NPI-0052) / Triphase Accelerator Corporation, BMS
recaticimab
(SHR-1209) / Jiangsu Hengrui Pharma
AZD0780
/ AstraZeneca
oprozomib
(ONX 0912) / Amgen
Junshida
(ongericimab) / Shanghai Junshi Biosci
ebronucimab
(AK102) / Akesobio
zetomipzomib
(KZR-616) / Kezar
NNC0385-0434
/ Novo Nordisk
simlukafusp alfa
(RG7461) / Roche
AZD8233
/ AstraZeneca
frovocimab
(LY3015014) / Eli Lilly
LGT209
/ Novartis
LXE408
/ Novartis
delanzomib
(CEP-18770) / Teva
CIVI 007
/ CiVi Biopharma
RG7652
/ Roche
SAL-003
(evolocumab biosimilar) / Shenzhen Salubris, Ligand
TQB3602
/ Sino Biopharm
ALN-PCS01
/ Novartis
AT04
/ AFFiRiS
ATX-304
/ Cambrian Biopharma
Affitope AT06A + adjuvant
/ AFFiRiS
BMS-844421
/ Ionis, BMS
BMS-962476
/ BMS
CVI-LM001
/ CVI Pharma
CX-13-608
/ Ningbo Shengjian Biomedical Technology
FHND6091
/ Sino Biopharm
GSK3494245
/ GSK
MEDI4166
/ AstraZeneca
PF-06815345
/ Pfizer
SPC5001
/ Roche
VERVE-101
/ Verve Therap
VLX1570
/ Vivolux
VXX-401
/ Vaxxinity
ralpancizumab
(RN317) / Pfizer
